Literature DB >> 8332105

Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin.

W Bellamy1, H Wakabayashi, M Takase, K Kawase, S Shimamura, M Tomita.   

Abstract

Candida albicans was found to be highly susceptible to inhibition and inactivation by lactoferricin B, a peptide produced by enzymatic cleavage of bovine lactoferrin. Effective concentrations of the peptide varied within the range of 18 to 150 micrograms/ml depending on the strain and the culture medium used. Its effect was lethal, causing a rapid loss of colony-forming capability. 14C-labeled lactoferricin B bound to C. albicans and the rate of binding appeared to be consistent with the rate of killing induced by the peptide. The extent of binding was diminished in the presence of Mg2+ or Ca2+ ions which acted to reduce its anticandidal effectiveness. Binding occurred optimally at pH 6.0 and killing was maximal near the same pH. Such evidence suggests the lethal effect of lactoferricin B results from its direct interaction with the cell surface. Cells exposed to lactoferricin B exhibited profound ultrastructural damage which appeared to reflect its induction of an autolytic response. These findings suggest that active peptides of lactoferrin could potentially contribute to the host defense against C. albicans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332105     DOI: 10.1007/bf00189377

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  23 in total

1.  Identification of the bactericidal domain of lactoferrin.

Authors:  W Bellamy; M Takase; K Yamauchi; H Wakabayashi; K Kawase; M Tomita
Journal:  Biochim Biophys Acta       Date:  1992-05-22

Review 2.  Polymyxin and related peptide antibiotics.

Authors:  D R Storm; K S Rosenthal; P E Swanson
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

Review 3.  Candida albicans: biology, genetics, and pathogenicity.

Authors:  M G Shepherd; R T Poulter; P A Sullivan
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

Review 4.  Oral candidiasis: pathogenesis and host defense.

Authors:  J B Epstein; E L Truelove; K T Izutzu
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

5.  Fungicidal effect of human lactoferrin against Candida albicans.

Authors:  T Soukka; J Tenovuo; M Lenander-Lumikari
Journal:  FEMS Microbiol Lett       Date:  1992-01-15       Impact factor: 2.742

Review 6.  The significance of iron in infection.

Authors:  J J Bullen
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

7.  Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans.

Authors:  G Marquis; S Montplaisir; S Garzon; H Strykowski; P Auger
Journal:  Lab Invest       Date:  1982-06       Impact factor: 5.662

8.  Anticandidal activity of major human salivary histatins.

Authors:  T Xu; S M Levitz; R D Diamond; F G Oppenheim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin.

Authors:  W Bellamy; M Takase; H Wakabayashi; K Kawase; M Tomita
Journal:  J Appl Bacteriol       Date:  1992-12

10.  Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms.

Authors:  R R Arnold; M Brewer; J J Gauthier
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  39 in total

Review 1.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

2.  Giardicidal activity of lactoferrin and N-terminal peptides.

Authors:  J M Turchany; S B Aley; F D Gillin
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

3.  Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.

Authors:  M E Kuipers; H G de Vries; M C Eikelboom; D K Meijer; P J Swart
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.

Authors:  Berthony Deslouches; Kazi Islam; Jodi K Craigo; Shruti M Paranjape; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Effects of bovine lactoferrin to oral Candida albicans and Candida glabrata isolates recovered from the saliva in elderly people.

Authors:  Akino Komatsu; Tazuko Satoh; Hiroyuki Wakabayashi; Fumiaki Ikeda
Journal:  Odontology       Date:  2015-01       Impact factor: 2.634

6.  Antibacterial activity in bovine lactoferrin-derived peptides.

Authors:  K S Hoek; J M Milne; P A Grieve; D A Dionysius; R Smith
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.

Authors:  Jamie S Mader; Daniel Smyth; Jean Marshall; David W Hoskin
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Oral lactoferrin treatment of experimental oral candidiasis in mice.

Authors:  Natsuko Takakura; Hiroyuki Wakabayashi; Hiroko Ishibashi; Susumu Teraguchi; Yoshitaka Tamura; Hideyo Yamaguchi; Shigeru Abe
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 10.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.